{"id":48518,"date":"2020-07-09T03:00:34","date_gmt":"2020-07-09T01:00:34","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=48518"},"modified":"2020-07-08T10:45:28","modified_gmt":"2020-07-08T08:45:28","slug":"commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/","title":{"rendered":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing"},"content":{"rendered":"<p><strong>The European Investment Bank (EIB) and CureVac<\/strong>, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a <strong>\u20ac75 million loan agreement to support the Company&#8217;s ongoing development of vaccines against infectious diseases<\/strong>, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections.<\/p>\n<p><a href=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg\"><img decoding=\"async\" class=\"wp-image-11987 aligncenter\" src=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920-300x196.jpg\" alt=\"\" width=\"467\" height=\"305\" srcset=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920-300x196.jpg 300w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920-768x501.jpg 768w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920-1024x668.jpg 1024w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg 1920w\" sizes=\"(max-width: 467px) 100vw, 467px\" \/><\/a><\/p>\n<p>El pr\u00e9stamo, adem\u00e1s, apoyar\u00e1 los esfuerzos de la Compa\u00f1\u00eda para ampliar sus actuales capacidades de producci\u00f3n certificadas por las buenas pr\u00e1cticas de fabricaci\u00f3n (BPF) y acelerar la finalizaci\u00f3n de su cuarto centro de producci\u00f3n en T\u00fcbingen (Alemania). La financiaci\u00f3n del BEI se conceder\u00e1 en tres tramos de 25 millones de euros una vez se hayan completado los hitos preestablecidos.<\/p>\n<p><strong>About CureVac&#8217;s mRNA technology platform<\/strong><\/p>\n<p>CureVac&#8217;s mRNA technology platform has shown potential in the clinical development and production of\u00a0mRNA based vaccines\u00a0and therapeutics. The Company&#8217;s proprietary RNAoptimizer\u00ae platform aims to optimize the properties of mRNA medicines based on its three core pillars: protein design, mRNA optimization and mRNA delivery. The technology can be tailored to induce varying degrees of immune responses against specific protein antigens of choice, potentially providing potent prophylactic vaccines for the prevention of infectious diseases at a low dose, such as Rabies, as well as immunotherapies for the treatment of cancer. The technology can also be adapted to avoid immune activation for purposes of protein therapy and antibodies, thereby providing potential new therapeutic modalities for patients suffering from a vast range of diseases.<\/p>\n<p>The\u00a0Infectious Diseases Finance Facility\u00a0(IDFF) of the EU&#8217;s Horizon 2020 programme backs the loan to CureVac. The IDFF is an example of successful collaboration between the European Commission and the EIB in the face of a health crisis. Through the IDFF, the EIB has supported 13 companies with total lending of \u20ac316 million for developing cures, vaccines and diagnostics against various infectious diseases, most prominently the coronavirus.<\/p>\n<h3>More information<\/h3>\n<p><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_20_1238\">Full news<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a \u20ac75 million loan agreement to support the Company&#8217;s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. El pr\u00e9stamo, adem\u00e1s, apoyar\u00e1 los [&hellip;]<\/p>\n","protected":false},"author":101012,"featured_media":21766,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4090,346,4094,4092,4088],"tags":[1629,700],"class_list":{"0":"post-48518","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economy-finance","8":"category-eu-news","9":"category-farmac","10":"category-health","11":"category-market","12":"tag-financing","13":"tag-vaccine-en","14":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a \u20ac75 million loan agreement to support the Company&#8217;s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. El pr\u00e9stamo, adem\u00e1s, apoyar\u00e1 los [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-09T01:00:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1252\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BECACDE1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BECACDE1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/\"},\"author\":{\"name\":\"BECACDE1\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/bf2f837cf3353e2161fe1087adbd728f\"},\"headline\":\"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing\",\"datePublished\":\"2020-07-09T01:00:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/money-3115981_1920.jpg\",\"keywords\":[\"financing\",\"vaccine\"],\"articleSection\":[\"Economy and Finance\",\"EU News\",\"Farmaceutical\",\"Health\",\"Market\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/\",\"name\":\"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/money-3115981_1920.jpg\",\"datePublished\":\"2020-07-09T01:00:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/money-3115981_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/money-3115981_1920.jpg\",\"width\":1920,\"height\":1252},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Market\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/market\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Economy and Finance\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/market\\\/economy-finance\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/bf2f837cf3353e2161fe1087adbd728f\",\"name\":\"BECACDE1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"caption\":\"BECACDE1\"},\"sameAs\":[\"http:\\\/\\\/www.cdealmeria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/","og_locale":"en_US","og_type":"article","og_title":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"The European Investment Bank (EIB) and CureVac, a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on optimised mRNA, entered into a \u20ac75 million loan agreement to support the Company&#8217;s ongoing development of vaccines against infectious diseases, including its vaccine candidate CVnCoV aimed at preventing SARS-CoV-2 infections. El pr\u00e9stamo, adem\u00e1s, apoyar\u00e1 los [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2020-07-09T01:00:34+00:00","og_image":[{"width":1920,"height":1252,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg","type":"image\/jpeg"}],"author":"BECACDE1","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"BECACDE1","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/"},"author":{"name":"BECACDE1","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/bf2f837cf3353e2161fe1087adbd728f"},"headline":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing","datePublished":"2020-07-09T01:00:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg","keywords":["financing","vaccine"],"articleSection":["Economy and Finance","EU News","Farmaceutical","Health","Market"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/","url":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/","name":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg","datePublished":"2020-07-09T01:00:34+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2019\/01\/money-3115981_1920.jpg","width":1920,"height":1252},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/commission-and-eib-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Market","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/market\/"},{"@type":"ListItem","position":4,"name":"Economy and Finance","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/market\/economy-finance\/"},{"@type":"ListItem","position":5,"name":"Commission and EIB provide CureVac with a \u20ac75 million financing for vaccine development and expansion of manufacturing"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/bf2f837cf3353e2161fe1087adbd728f","name":"BECACDE1","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","caption":"BECACDE1"},"sameAs":["http:\/\/www.cdealmeria.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/48518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/101012"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=48518"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/48518\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/21766"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=48518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=48518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=48518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}